Home Association between SNP rs13376333 and rs1131820 in the KCNN3 gene and atrial fibrillation in the Chinese Han population
Article
Licensed
Unlicensed Requires Authentication

Association between SNP rs13376333 and rs1131820 in the KCNN3 gene and atrial fibrillation in the Chinese Han population

  • Zhurong Luo , Chenghui Yan , Wenli Zhang , Xiaoli Shen , Weixing Zheng , Fengping Chen , Xiaozhi Cao , Yuhui Yang , Xianliang Lin , Zhiqing Wang and Mingfang Huang EMAIL logo
Published/Copyright: June 30, 2014

Abstract

Background: The small conductance calcium-activated potassium, subfamily N, member 3 (KCNN3) gene rs13376333 and rs1131820 have been shown to be strongly associated with lone atrial fibrillation (AF), while replication association studies between rs13376333 in KCNN3 gene and risk of AF showed conflicting results. The current study tried to validate the impact of SNP rs13376333 and rs1131820 of KCNN3 gene on the risk of AF in the Chinese Han population.

Methods: A total of 889 AF patients and 1015 controls were enrolled. Two hundred and seventy-eight cases of AF were lone AF. KCNN3 gene SNP rs13376333 and rs1131820 were genotyped by allele-specific MALDI-TOF mass spectrometry.

Results: The genotype distribution and allele frequency of rs13376333 polymorphism were not different between total AF patients and controls. However, the genotype distribution of rs13376333 polymorphism was significantly different between lone AF and control group (p<0.001); and T allele frequency was significantly higher in lone AF group than that in controls (7.6% vs 3.6%, p<0.001). Multivariable logistic regression analysis showed that T allele carriers of rs13376333 was significantly associated with lone AF (OR=2.31, 95% CI 1.41–3.78, p=0.001). No relationship between rs1131820 polymorphism and total AF or lone AF was found in this study.

Conclusions:KCNN3 rs13376333 polymorphism was associated with lone AF in the Chinese Han population and the T allele carriers may be an independent predictive factor for lone AF.


aZhurong Luo, Chenghui Yan and Wenli Zhang contributed equally to this work.
Corresponding author: Mingfang Huang, Department of Cardiology, Fuzhou General Hospital, Xiamen University, Fuzhou 350025, P.R. China, Phone: +86 591 22859321, Fax: +86 591 83724075, E-mail:

Acknowledgments

We thank the study participants for their important support of this research. The present study was supported by the Natural Science Foundation of Fujian Province, China (Grant No. 2009J01182 and 2013J01342) and the Key Programs of Science and Technology Commission Foundation of Fujian Province, China (Grant No.2007Y0029 and 2013Y5011).

Author contributions:

All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Financial support: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Hu D, Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. J Am Coll Cardiol 2008;52:865–8.10.1016/j.jacc.2008.05.042Search in Google Scholar PubMed

2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Am Med Assoc 2001;285:2370–5.10.1001/jama.285.18.2370Search in Google Scholar PubMed

3. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946–52.10.1161/01.CIR.98.10.946Search in Google Scholar PubMed

4. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. J Am Med Assoc 1994;271:840–4.10.1001/jama.1994.03510350050036Search in Google Scholar

5. Mahida S, Lubitz SA, Rienstra M, Milan DJ, Ellinor PT. Monogenic atrial fibrillation as pathophysiological paradigms. Cardiovasc Res 2011;89:692–700.10.1093/cvr/cvq381Search in Google Scholar PubMed PubMed Central

6. Fox CS, Parise H, D’Agostino RB, Sr., Lloyd-Jones DM, Vasan RS, Wang TJ, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. J Am Med Assoc 2004;291:2851–5.10.1001/jama.291.23.2851Search in Google Scholar PubMed

7. Arnar DO, Thorvaldsson S, Manolio TA, Thorgeirsson G, Kristjansson K, Hakonarson H, et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 2006;27:708–12.10.1093/eurheartj/ehi727Search in Google Scholar PubMed

8. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007;448:353–7.10.1038/nature06007Search in Google Scholar PubMed

9. Benjamin EJ, Rice KM, Arking DE, Pfeufer A, van Noord C, Smith AV, et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet 2009;41:879–81.10.1038/ng.416Search in Google Scholar PubMed PubMed Central

10. Gudbjartsson DF, Holm H, Gretarsdottir S, Thorleifsson G, Walters GB, Thorgeirsson G, et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet 2009;41:876–8.10.1038/ng.417Search in Google Scholar PubMed PubMed Central

11. Pfeufer A, van Noord C, Marciante KD, Arking DE, Larson MG, Smith AV, et al. Genome-wide association study of PR interval. Nat Genet 2010;42:153–910.1038/ng.517Search in Google Scholar PubMed PubMed Central

12. Ellinor PT, Lunetta KL, Glazer NL, Pfeufer A, Alonso A, Chung MK, et al. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 2010;42:240–4.10.1038/ng.537Search in Google Scholar PubMed PubMed Central

13. Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 2012;44:670–5.10.1038/ng.2261Search in Google Scholar PubMed PubMed Central

14. den Hoed M, Eijgelsheim M, Esko T, Brundel BJ, Peal DS, Evans DM, et al. Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet 2013;45:621–31.10.1038/ng.2610Search in Google Scholar PubMed PubMed Central

15. Kiliszek M, Franaszczyk M, Kozluk E, Lodzinski P, Piatkowska A, Broda G, et al. Association between variants on chromosome 4q25, 16q22 and 1q21 and atrial fibrillation in the Polish population. PLoS One 2011;6:e21790.10.1371/journal.pone.0021790Search in Google Scholar PubMed PubMed Central

16. Chang SH, Chang SN, Hwang JJ, Chiang FT, Tseng CD, Lee JK, et al. Significant association of rs13376333 in KCNN3 on chromosome 1q21 with atrial fibrillation in a Taiwanese population. Circ J 2012;76:184–8.10.1253/circj.CJ-11-0525Search in Google Scholar PubMed

17. Li C, Wang F, Yang Y, Fu F, Xu C, Shi L, et al. Significant association of SNP rs2106261 in the ZFHX3 gene with atrial fibrillation in a Chinese Han GeneID population. Hum Genet 2011;129:239–46.10.1007/s00439-010-0912-6Search in Google Scholar PubMed PubMed Central

18. Olesen MS, Jabbari J, Holst AG, Nielsen JB, Steinbruchel DA, Jespersen T, et al. Screening of KCNN3 in patients with early-onset lone atrial fibrillation. Europace 2011;13:963–7.10.1093/europace/eur007Search in Google Scholar PubMed

19. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the North American society of pacing and electrophysiology. Circulation 2001;104: 2118–50.10.1161/circ.104.17.2118Search in Google Scholar

20. Huang M, Gai X, Yang X, Hou J, Lan X, Zheng W, et al. Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease. Clin Chem Lab Med 2009;47:32–7.10.1515/CCLM.2009.023Search in Google Scholar PubMed

21. Jurinke C, Oeth P, van den Boom D. MALDI-TOF mass spectrometry: a versatile tool for high-performance DNA analysis. Mol Biotechnol 2004;26:147–64.10.1385/MB:26:2:147Search in Google Scholar

22. Tuteja D, Xu D, Timofeyev V, Lu L, Sharma D, Zhang Z, et al. Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes. Am J Physiol Heart Circ Physiol 2005;289:H2714–23.10.1152/ajpheart.00534.2005Search in Google Scholar

23. Diness JG, Skibsbye L, Jespersen T, Bartels ED, Sorensen US, Hansen RS, et al. Effects on atrial fibrillation in aged hypertensive rats by Ca(2+)-activated K(+) channel inhibition. Hypertension 2011;57:1129–35.10.1161/HYPERTENSIONAHA.111.170613Search in Google Scholar

24. Skibsbye L, Diness JG, Sorensen US, Hansen RS, Grunnet M. The duration of pacing-induced atrial fibrillation is reduced in vivo by inhibition of small conductance Ca(2+)-activated K(+) channels. J Cardiovasc Pharmacol 2011;57:672–81.10.1097/FJC.0b013e318217943dSearch in Google Scholar

25. Qi XY, Diness JG, Brundel BJ, Zhou XB, Naud P, Wu CT, et al. Role of small-conductance calcium-activated potassium channels in atrial electrophysiology and fibrillation in the dog. Circulation 2014;129:430–40.10.1161/CIRCULATIONAHA.113.003019Search in Google Scholar

26. Ling TY, Wang XL, Chai Q, Lau TW, Koestler CM, Park SJ, et al. Regulation of the SK3 channel by microRNA-499 – potential role in atrial fibrillation. Heart Rhythm 2013;10:1001–9.10.1016/j.hrthm.2013.03.005Search in Google Scholar

27. Zhang XD, Timofeyev V, Li N, Myers RE, Zhang DM, Singapuri A, et al. Critical roles of a small conductance Ca2+-activated K+ channel (SK3) in the repolarization process of atrial myocytes. Cardiovasc Res 2014;101:317–25.10.1093/cvr/cvt262Search in Google Scholar

28. Roberts JD, Gollob MH. Impact of genetic discoveries on the classification of lone atrial fibrillation. J Am Coll Cardiol 2010;55:705–12.10.1016/j.jacc.2009.12.005Search in Google Scholar

29. De Jong AM, Maass AH, Oberdorf-Maass SU, Van Veldhuisen DJ, Van Gilst WH, Van Gelder IC. Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. Cardiovasc Res 2011;89:754–65.10.1093/cvr/cvq357Search in Google Scholar

30. Fatini C, Sticchi E, Gensini F, Gori AM, Marcucci R, Lenti M, et al. Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility. Int J Cardiol 2007;120:59–65.10.1016/j.ijcard.2006.08.079Search in Google Scholar

Received: 2014-5-7
Accepted: 2014-6-10
Published Online: 2014-6-30
Published in Print: 2014-12-1

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. CCLM Award for The Most Cited Paper Recently Published
  4. Laboratory preparedness to face infectious outbreaks. Ebola and beyond
  5. Reviews
  6. Determination of reference limits: statistical concepts and tools for sample size calculation
  7. Recent advances in physiological lipoprotein metabolism
  8. New laboratory markers for the management of rheumatoid arthritis patients
  9. General Clinical Chemistry and Laboratory Medicine
  10. The impact of repeat-testing of common chemistry analytes at critical concentrations
  11. Performance of CKD-EPI equation to estimate glomerular filtration rate as compared to MDRD equation in South Brazilian individuals in each stage of renal function
  12. The serum uromodulin level is associated with kidney function
  13. Efficient assessment of peripheral blood lymphocytosis in adults: developing new thresholds for blood smear review by pathologists
  14. Performance evaluation of Sysmex XN hematology analyzer in umbilical cord blood: a comparison study with Sysmex XE-2100
  15. UF-1000i: validation of the body fluid mode for counting cells in body fluids
  16. Newborn screening for haemoglobinopathies by high performance liquid chromatography (HPLC): diagnostic utility of different approaches in resource-poor settings
  17. Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies
  18. Reference Values and Biological Variations
  19. Thyroid-stimulating hormone reference range and factors affecting it in a nationwide random sample
  20. Reference ranges for serum β-trace protein in neonates and children younger than 1 year of age
  21. A multicenter nationwide reference intervals study for common biochemical analytes in Turkey using Abbott analyzers
  22. Serum reference intervals of homoarginine, ADMA, and SDMA in the Study of Health in Pomerania
  23. Cancer Diagnostics
  24. Low SOX17 expression: prognostic significance in de novo acute myeloid leukemia with normal cytogenetics
  25. Results of first proficiency test for KRAS testing with formalin-fixed, paraffin-embedded cell lines in China
  26. Aberrant hypermethylation of CTNNA1 gene is associated with higher IPSS risk in patients with myelodysplastic syndrome
  27. Cardiovascular Diseases
  28. Association between SNP rs13376333 and rs1131820 in the KCNN3 gene and atrial fibrillation in the Chinese Han population
  29. Acknowledgment
  30. Acknowledgment
  31. Letters to the Editor
  32. Interference in thyroid hormones with Roche immunoassays: an unfinished story
  33. Discrepant results in plasma, but not serum in the Beckman Coulter DxI Access HYPERsensitive hTSH 3rd generation assay affect the management of differentiated thyroid cancer and hyperthyroid patients
  34. Improper serum separation on gel tubes: a trivial laboratory problem or an indicator of monoclonal gammopathy?
  35. Analytical comparison of the new point-of-care troponin T immunoassay on AQT90Flex® analyzer (Radiometer) and the high-sensitivity troponin T immunoassay on ModularE170® (Roche Diagnostics)
  36. Performance characteristics of the enzymatic Abbott Architect HbA1c whole blood assay
  37. Multi-center proficiency tests for Lab-MELD score diagnostics to improve the quality and safety for patients awaiting liver transplantation
  38. The apolipoprotein B/apolipoprotein A-I ratio in healthy men with normolipidemia: limits of variation and relationship with other lipid parameters
  39. Validity and reliability of the 13C-methionine breath test for the detection of moderate hyperhomocysteinemia in Mexican adults; statistical issues in validity and reliability analysis
  40. Enzymatic and endpoint methods yield comparable adenosine deaminase activity in pleural fluid samples
  41. Congress Abstract
  42. 5th Italian GREAT Network Congress
  43. Congress of Laboratory Medicine and Clinical Chemistry
Downloaded on 26.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2014-0491/html
Scroll to top button